During the past decade, Humanitas Mirasole S.p.a. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Humanitas Mirasole S.p.a." #1 collaborator was "Humanitas Hospital, Italy" with 2 trials as a collaborator and "Istituto Oncologico Veneto IRCCS" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Humanitas Mirasole S.p.a." are "Esophageal Neoplasms" (2 trials), "Colon Neoplasms" (1 trials), "Colonic Neoplasms" (1 trials), "Gastric Neoplasm" (1 trials) and "Stomach Neoplasm" (1 trials). Many other conditions were trialed in "Humanitas Mirasole S.p.a." in a lesser frequency.

Most popular intervention types in "Humanitas Mirasole S.p.a." are "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Promotion of competences of participant involved in the management of the post operative period" (1 trials). Other intervention names were less common.

The vast majority of trials in "Humanitas Mirasole S.p.a." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Humanitas Mirasole S.p.a.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Humanitas Mirasole S.p.a., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Humanitas Mirasole S.p.a., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".